FDA Approved: KOSELUGO — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved KOSELUGO (selumetinib) as an original application for pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibromas

Drugs mentioned

• Koselugo (selumetinib)

Snippet

ORIG AP for KOSELUGO (SELUMETINIB)